Method for preventing and treating Alzheimer's disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 20, 2011
Grant Date -
Jan 1, 2009
app pub date -
Jul 6, 2005
filing date -
Jul 13, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
is not DAEFRH, said compound having a binding capacity to an antibody being specific for the natural N-terminal Aβ42 sequence DAEFRH, and 5-mers thereof having a binding capacity to said antibody being specific for the natural N-terminal Aβ42 sequence DAEFRH, for the preparation of a vaccine for Alzheimer's disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully